Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) EBT (2016 - 2025)

iBio (IBIO) has disclosed EBT for 16 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • Quarterly EBT fell 106.07% to -$9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.7 million through Dec 2025, down 62.38% year-over-year, with the annual reading at -$18.4 million for FY2025, 11.76% down from the prior year.
  • EBT for Q4 2025 was -$9.0 million at iBio, down from -$5.7 million in the prior quarter.
  • The five-year high for EBT was -$3.2 million in Q2 2024, with the low at -$10.6 million in Q4 2022.
  • Average EBT over 5 years is -$6.3 million, with a median of -$5.8 million recorded in 2021.
  • The sharpest move saw EBT plummeted 185.09% in 2021, then surged 57.51% in 2023.
  • Over 5 years, EBT stood at -$7.2 million in 2021, then plummeted by 46.79% to -$10.6 million in 2022, then soared by 57.51% to -$4.5 million in 2023, then increased by 2.76% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$9.0 million, -$5.7 million, and -$5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.